NCVLX
Price
$13.66
Change
-$0.17 (-1.23%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

NCVLX vs VMVAX

Header iconNCVLX vs VMVAX Comparison
Open Charts NCVLX vs VMVAXBanner chart's image
Nuance Concentrated Value Institutional
Price$13.66
Change-$0.17 (-1.23%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NCVLX vs VMVAX Comparison Chart
Loading...
VS
NCVLX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCVLX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. NCVLX (190M). VMVAX pays higher dividends than NCVLX: VMVAX (2.14) vs NCVLX (1.75). NCVLX was incepted earlier than VMVAX: NCVLX (13 years) vs VMVAX (13 years). NCVLX is a more actively managed with annual turnover of: 67.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than NCVLX: VMVAX (3000) vs NCVLX (10000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. NCVLX (22.95). VMVAX return over 5 years is better than : 48.82 vs. NCVLX (-1.19).
NCVLXVMVAXNCVLX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD10.64714.94671%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets190M30.5B1%
Annual Yield % from dividends1.752.1482%
Returns for 1 year22.9525.3591%
Returns for 3 years-12.0520.71-58%
Returns for 5 years-1.1948.82-2%
Returns for 10 years6.49100.886%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio